Annual Short Term Debt
$1.08 B
-$1.17 B-52.02%
31 December 2023
Summary:
Abbott Laboratories annual short term debt is currently $1.08 billion, with the most recent change of -$1.17 billion (-52.02%) on 31 December 2023. During the last 3 years, it has risen by +$860.00 million (+390.91%). ABT annual short term debt is now -83.11% below its all-time high of $6.39 billion, reached on 31 December 2010.ABT Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$2.15 B
+$539.00 M+33.37%
30 September 2024
Summary:
Abbott Laboratories quarterly short term debt is currently $2.15 billion, with the most recent change of +$539.00 million (+33.37%) on 30 September 2024. Over the past year, it has increased by +$1.10 billion (+104.95%). ABT quarterly short term debt is now -66.60% below its all-time high of $6.45 billion, reached on 31 March 2010.ABT Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABT Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -52.0% | +105.0% |
| 3 y3 years | +390.9% | +126.5% |
| 5 y5 years | +421.7% | +47.7% |
ABT Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -52.0% | +390.9% | -5.7% | >+9999.0% |
| 5 y | 5 years | -52.0% | +421.7% | -5.7% | >+9999.0% |
| alltime | all time | -83.1% | +778.8% | -66.6% | >+9999.0% |
Abbott Laboratories Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.15 B(+33.4%) |
| June 2024 | - | $1.61 B(-19.7%) |
| Mar 2024 | - | $2.01 B(+86.1%) |
| Dec 2023 | $1.08 B(-52.0%) | $1.08 B(+2.8%) |
| Sept 2023 | - | $1.05 B(-54.0%) |
| June 2023 | - | $2.28 B(-0.0%) |
| Mar 2023 | - | $2.29 B(+1.5%) |
| Dec 2022 | $2.25 B(+198.5%) | $2.25 B(+101.5%) |
| Sept 2022 | - | $1.12 B(>+9900.0%) |
| June 2022 | - | $5.00 M(+25.0%) |
| Mar 2022 | - | $4.00 M(-99.5%) |
| Dec 2021 | $754.00 M(+242.7%) | $754.00 M(-20.7%) |
| Sept 2021 | - | $951.00 M(-0.3%) |
| June 2021 | - | $954.00 M(-0.1%) |
| Mar 2021 | - | $955.00 M(+334.1%) |
| Dec 2020 | $220.00 M(-85.1%) | $220.00 M(+2.8%) |
| Sept 2020 | - | $214.00 M(-85.7%) |
| June 2020 | - | $1.50 B(+1.8%) |
| Mar 2020 | - | $1.47 B(-0.7%) |
| Dec 2019 | $1.48 B(+614.0%) | $1.48 B(+1.4%) |
| Sept 2019 | - | $1.46 B(+587.7%) |
| June 2019 | - | $212.00 M(+1.4%) |
| Mar 2019 | - | $209.00 M(+1.0%) |
| Dec 2018 | $207.00 M(-71.0%) | $207.00 M(-95.2%) |
| Sept 2018 | - | $4.27 B(+404.6%) |
| June 2018 | - | $847.00 M(+14.9%) |
| Mar 2018 | - | $737.00 M(+3.2%) |
| Dec 2017 | $714.00 M(-46.1%) | $714.00 M(-0.1%) |
| Sept 2017 | - | $715.00 M(+223.5%) |
| June 2017 | - | $221.00 M(+5.2%) |
| Mar 2017 | - | $210.00 M(-84.2%) |
| Dec 2016 | $1.32 B(-57.7%) | $1.32 B(-47.7%) |
| Sept 2016 | - | $2.54 B(-12.5%) |
| June 2016 | - | $2.90 B(+10.8%) |
| Mar 2016 | - | $2.61 B(-16.5%) |
| Dec 2015 | $3.13 B(-29.5%) | $3.13 B(+30.3%) |
| Sept 2015 | - | $2.40 B(-17.1%) |
| June 2015 | - | $2.90 B(-2.5%) |
| Mar 2015 | - | $2.97 B(-33.0%) |
| Dec 2014 | $4.44 B(+39.8%) | $4.44 B(-3.2%) |
| Sept 2014 | - | $4.58 B(+15.6%) |
| June 2014 | - | $3.96 B(-9.5%) |
| Mar 2014 | - | $4.38 B(+38.0%) |
| Dec 2013 | $3.17 B(+32.7%) | $3.17 B(-34.7%) |
| Sept 2013 | - | $4.86 B(+7.4%) |
| June 2013 | - | $4.52 B(+24.4%) |
| Mar 2013 | - | $3.64 B(+52.1%) |
| Dec 2012 | $2.39 B(-29.2%) | $2.39 B(-43.4%) |
| Sept 2012 | - | $4.22 B(-30.5%) |
| June 2012 | - | $6.08 B(+27.1%) |
| Mar 2012 | - | $4.79 B(+41.8%) |
| Dec 2011 | $3.37 B(-47.2%) | $3.37 B(-6.9%) |
| Sept 2011 | - | $3.62 B(-35.2%) |
| June 2011 | - | $5.59 B(-10.6%) |
| Mar 2011 | - | $6.25 B(-2.2%) |
| Dec 2010 | $6.39 B(+23.2%) | $6.39 B(+10.1%) |
| Sept 2010 | - | $5.81 B(-1.1%) |
| June 2010 | - | $5.87 B(-9.0%) |
| Mar 2010 | - | $6.45 B(+24.3%) |
| Dec 2009 | $5.19 B(+90.0%) | $5.19 B(+27.3%) |
| Sept 2009 | - | $4.08 B(-5.9%) |
| June 2009 | - | $4.33 B(+7.3%) |
| Mar 2009 | - | $4.04 B(+47.8%) |
| Dec 2008 | $2.73 B(+0.2%) | $2.73 B(+30.3%) |
| Sept 2008 | - | $2.10 B(-61.4%) |
| June 2008 | - | $5.43 B(+29.9%) |
| Mar 2008 | - | $4.18 B(+53.3%) |
| Dec 2007 | $2.73 B(-49.5%) | $2.73 B(-52.7%) |
| Sept 2007 | - | $5.76 B(+0.8%) |
| June 2007 | - | $5.72 B(-3.6%) |
| Mar 2007 | - | $5.94 B(+9.9%) |
| Dec 2006 | $5.40 B | $5.40 B(+178.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2006 | - | $1.94 B(-14.0%) |
| June 2006 | - | $2.25 B(+5.2%) |
| Mar 2006 | - | $2.14 B(+3.8%) |
| Dec 2005 | $2.06 B(+3.5%) | $2.06 B(-41.6%) |
| Sept 2005 | - | $3.53 B(+247.4%) |
| June 2005 | - | $1.02 B(-59.0%) |
| Mar 2005 | - | $2.48 B(+24.4%) |
| Dec 2004 | $1.99 B(-21.5%) | $1.99 B(+7.5%) |
| Sept 2004 | - | $1.85 B(-18.7%) |
| June 2004 | - | $2.28 B(+32.0%) |
| Mar 2004 | - | $1.73 B(-31.9%) |
| Dec 2003 | $2.54 B(+18.1%) | $2.54 B(-6.7%) |
| Sept 2003 | - | $2.72 B(+48.7%) |
| June 2003 | - | $1.83 B(-16.9%) |
| Mar 2003 | - | $2.20 B(+2.4%) |
| Dec 2002 | $2.15 B(-27.2%) | $2.15 B(-13.4%) |
| Sept 2002 | - | $2.48 B(+3.8%) |
| June 2002 | - | $2.39 B(-7.2%) |
| Mar 2002 | - | $2.58 B(-12.8%) |
| Dec 2001 | $2.95 B(+516.0%) | $2.95 B(+1.1%) |
| Sept 2001 | - | $2.92 B(-9.9%) |
| June 2001 | - | $3.24 B(-45.7%) |
| Mar 2001 | - | $5.97 B(+1144.5%) |
| Dec 2000 | $479.45 M(-46.5%) | $479.45 M(-12.4%) |
| Sept 2000 | - | $547.02 M(+53.8%) |
| June 2000 | - | $355.59 M(-60.9%) |
| Mar 2000 | - | $909.12 M(+1.4%) |
| Dec 1999 | $896.27 M(-49.0%) | $896.27 M(+2.7%) |
| Sept 1999 | - | $872.79 M(-11.2%) |
| June 1999 | - | $982.86 M(-23.6%) |
| Mar 1999 | - | $1.29 B(-26.9%) |
| Dec 1998 | $1.76 B(-1.3%) | $1.76 B(+23.9%) |
| Sept 1998 | - | $1.42 B(-9.9%) |
| June 1998 | - | $1.58 B(+22.1%) |
| Mar 1998 | - | $1.29 B(-27.6%) |
| Dec 1997 | $1.78 B(+28.7%) | $1.78 B(+8.8%) |
| Sept 1997 | - | $1.64 B(+12.0%) |
| June 1997 | - | $1.46 B(+21.7%) |
| Mar 1997 | - | $1.20 B(-13.1%) |
| Dec 1996 | $1.38 B(+31.8%) | $1.38 B(-4.7%) |
| Sept 1996 | - | $1.45 B(-13.1%) |
| June 1996 | - | $1.67 B(+147.4%) |
| Mar 1996 | - | $675.34 M(-35.7%) |
| Dec 1995 | $1.05 B(+35.9%) | $1.05 B(+12.0%) |
| Sept 1995 | - | $937.19 M(+13.0%) |
| June 1995 | - | $829.59 M(-6.1%) |
| Mar 1995 | - | $883.55 M(+14.4%) |
| Dec 1994 | $772.50 M(-8.4%) | $772.50 M(+1.1%) |
| Sept 1994 | - | $764.26 M(+2.5%) |
| June 1994 | - | $745.80 M(+10.4%) |
| Mar 1994 | - | $675.43 M(-19.9%) |
| Dec 1993 | $843.59 M(-7.9%) | $843.59 M(-13.2%) |
| Sept 1993 | - | $971.40 M(-3.2%) |
| June 1993 | - | $1.00 B(+15.0%) |
| Mar 1993 | - | $872.60 M(-4.8%) |
| Dec 1992 | $916.30 M(+68.3%) | $916.30 M(+6.9%) |
| Sept 1992 | - | $857.40 M(+61.3%) |
| June 1992 | - | $531.50 M(-21.0%) |
| Mar 1992 | - | $672.50 M(+23.6%) |
| Dec 1991 | $544.30 M(-18.0%) | $544.30 M(+2.1%) |
| Sept 1991 | - | $533.00 M(-8.9%) |
| June 1991 | - | $584.80 M(+0.4%) |
| Mar 1991 | - | $582.60 M(-12.2%) |
| Dec 1990 | $663.80 M(+120.9%) | $663.80 M(-29.0%) |
| Sept 1990 | - | $935.00 M(+25.5%) |
| June 1990 | - | $745.20 M(+39.0%) |
| Mar 1990 | - | $536.30 M(+78.5%) |
| Dec 1989 | $300.50 M(-39.1%) | $300.50 M(-39.1%) |
| Dec 1988 | $493.30 M(-18.7%) | $493.30 M(-18.7%) |
| Dec 1987 | $606.40 M(+2.5%) | $606.40 M(+2.5%) |
| Dec 1986 | $591.70 M(+381.4%) | $591.70 M(+381.4%) |
| Dec 1985 | $122.90 M(-54.9%) | $122.90 M(-54.9%) |
| Dec 1984 | $272.70 M | $272.70 M |
FAQ
- What is Abbott Laboratories annual short term debt?
- What is the all time high annual short term debt for Abbott Laboratories?
- What is Abbott Laboratories annual short term debt year-on-year change?
- What is Abbott Laboratories quarterly short term debt?
- What is the all time high quarterly short term debt for Abbott Laboratories?
- What is Abbott Laboratories quarterly short term debt year-on-year change?
What is Abbott Laboratories annual short term debt?
The current annual short term debt of ABT is $1.08 B
What is the all time high annual short term debt for Abbott Laboratories?
Abbott Laboratories all-time high annual short term debt is $6.39 B
What is Abbott Laboratories annual short term debt year-on-year change?
Over the past year, ABT annual short term debt has changed by -$1.17 B (-52.02%)
What is Abbott Laboratories quarterly short term debt?
The current quarterly short term debt of ABT is $2.15 B
What is the all time high quarterly short term debt for Abbott Laboratories?
Abbott Laboratories all-time high quarterly short term debt is $6.45 B
What is Abbott Laboratories quarterly short term debt year-on-year change?
Over the past year, ABT quarterly short term debt has changed by +$1.10 B (+104.95%)